Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Professional, scientific, and technical services save search
Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split
Published: 2023-12-05 (Crawled : 22:00) - globenewswire.com
TIL | News | $0.3411 0.32% 0.32% 270K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
TransCode Therapeutics To Present Phase 0 Data at 2023 San Antonio Breast Cancer Symposium
Published: 2023-12-05 (Crawled : 14:00) - globenewswire.com
RNAZ | News 1 d | $0.2342 2.72% 2.65% 1.1M
|
Professional, Scientific, and T...
|
| O: 1.91%
H: 0.0%
C: 0.0%
breast symposium cancer therapeutics
Todays' Top-5
Biomea Fusion Announces Health Canada Clearance of Clinical Trial Application (CTA) for BMF-219 in Type 1 Diabetes
Published: 2023-12-05 (Crawled : 13:30) - globenewswire.com
BMEA | News A | $19.01 -3.99% -4.16% 2.5M
|
Professional, Scientific, and T...
|
| O: 20.69%
H: 3.01%
C: -9.69%
bmf-219 health clearance canada application trial diabetes
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages The Beauty Health Company Investors to Secure Counsel Before Important Deadline in Securities Class Action - SKIN
Published: 2023-12-04 (Crawled : 00:00) - prnewswire.com
SKIN | News | $2.805 -5.87% -6.24% 3.3M
|
Professional, Scientific, and T...
|
| O: 3.47%
H: 0.34%
C: -5.7%
NKLA | $0.9714 -3.82% -3.97% 40M
|
Consumer Durables
|
| O: 0.0%
H: 0.99%
C: -3.96%
company health deadline beauty skin
ROSEN, LEADING INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - EGRX
Published: 2023-12-04 (Crawled : 00:00) - prnewswire.com
SKIN | News | $2.805 -5.87% -6.24% 3.3M
|
Professional, Scientific, and T...
|
| O: 3.47%
H: 0.34%
C: -5.7%
ABR | News | $13.67 -1.37% 0.29% 6.2M
|
Finance
|
| O: 1.86%
H: 2.05%
C: 0.0%
EGRX | News | $5.98 -4.32% -4.52% 290K
|
Health Technology
|
| O: 4.07%
H: 0.96%
C: -4.31%
ROSEN, A LEADING LAW FIRM, Encourages Arbor Realty Trust, Inc. Investors to Inquire About Securities Class Action Investigation - ABR
Published: 2023-12-05 (Crawled : 00:00) - prnewswire.com
SKIN | News | $2.805 -5.87% -6.24% 3.3M
|
Professional, Scientific, and T...
|
| O: 3.47%
H: 0.34%
C: -5.7%
ABR | News | $13.67 -1.37% 0.29% 6.2M
|
Finance
|
| O: 1.86%
H: 2.05%
C: 0.0%
EGRX | News | $5.98 -4.32% -4.52% 290K
|
Health Technology
|
| O: 4.07%
H: 0.96%
C: -4.31%
realty
TScan Therapeutics to Host Virtual KOL Event to Discuss Results from Ongoing Phase 1 Trial of TSC-100 and TSC-101 Presented at the 65th ASH Annual Meeting and Exposition
Published: 2023-12-04 (Crawled : 21:00) - globenewswire.com
TCRX | $6.74 10.13% 9.2% 140K
|
Professional, Scientific, and T...
|
| O: -7.49%
H: 16.36%
C: 14.0%
tsc-100 tsc-101 ongoing meeting trial therapeutics results
TransCode Therapeutics Announces Closing of $1.2 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
Published: 2023-12-04 (Crawled : 21:00) - globenewswire.com
RNAZ | News 1 d | $0.2342 2.72% 2.65% 1.1M
|
Professional, Scientific, and T...
|
| O: 1.91%
H: 0.0%
C: 0.0%
nasdaq direct offering therapeutics
Endonovo Signs Definitive Agreement to Sell SofPulse® Brand Business and IP to SofPulse Inc. for a minimum of $50 Million
Published: 2023-12-04 (Crawled : 14:00) - globenewswire.com
ENDV | $0.0084 19.05% 6M
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
sofpulse business agreement
Sunshine Biopharma Moves Principal Office to New York City
Published: 2023-12-04 (Crawled : 13:30) - globenewswire.com
SBFM | $0.28 4.48% 4.29% 60K
|
Professional, Scientific, and T...
|
| O: 0.11%
H: 0.0%
C: 0.0%
biopharma city
Gain Therapeutics to Participate in FORCE Family Office Event with Zacks Small-Cap Research
Published: 2023-12-04 (Crawled : 13:00) - globenewswire.com
GANX | $2.435 3.62% 3.49% 41K
|
Professional, Scientific, and T...
|
| O: 6.54%
H: 0.0%
C: 0.0%
research family therapeutics
Panbela Announces Publication of Abstract Titled: Evaluation of Myeloma Cell Lines Viability Following Administration of SBP-101 and DFMO Polyamine Inhibitors
Published: 2023-12-04 (Crawled : 13:00) - globenewswire.com
PBLA | $0.5191 -0.02% 120K
|
Professional, Scientific, and T...
|
| O: 6.75%
H: 0.0%
C: 0.0%
sbp-101 publication cell
TScan Therapeutics Expands Manufacturing Leadership with the Appointment of Justin McCue, Ph.D., as Chief Technology Officer
Published: 2023-12-04 (Crawled : 12:00) - globenewswire.com
TCRX | $6.74 10.13% 9.2% 140K
|
Professional, Scientific, and T...
|
| O: -0.31%
H: 0.0%
C: 0.0%
technology therapeutics
LianBio Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
Published: 2023-12-01 (Crawled : 21:00) - globenewswire.com
LIAN | $4.14 -0.48% -0.48% 81K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
unsolicited proposal
Verve Therapeutics Announces Closing of Public Offering of Common Stock, Full Exercise by Underwriters of Option to Purchase Additional Shares and Closing of Concurrent Private Placement
Published: 2023-12-01 (Crawled : 21:00) - globenewswire.com
VERV 4 d | $11.57 -3.66% -3.8% 1.2M
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
LLY | News 4 d | $588.15 0.42% 0.09% 2M
|
Health Technology
| Email alert
Add to watchlist
offering therapeutics
GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
WGS | $1.61 -7.47% -8.07% 170K
|
Professional, Scientific, and T...
|
| O: -0.57%
H: 0.0%
C: 0.0%
meeting
Gain Therapeutics Announces Preclinical Data Showing Restoration of Enzymatic Function with Novel Allosteric Regulators in GM1 Gangliosidosis Model
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
GANX | $2.435 3.62% 3.49% 41K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
preclinical therapeutics
BriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic Tumor
Published: 2023-11-30 (Crawled : 20:00) - biospace.com/
BCTX | $5.35 0.0% 25K
|
Professional, Scientific, and T...
|
| O: 0.2%
H: 3.7%
C: 3.12%
tumor
News Kommuniqué V
Published: 2023-11-30 (Crawled : 18:00) - clinuvel.com
CLVLY | $11.17 13.07% 510
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
CLVLF | $10.05 35.85% 860
|
Health Technology
| Email alert
Add to watchlist
SKIN Investors Have Opportunity to Lead The Beauty Health Company Securities Fraud Lawsuit
Published: 2023-11-29 (Crawled : 15:00) - prnewswire.com
SKIN | News | $2.805 -5.87% -6.24% 3.3M
|
Professional, Scientific, and T...
|
| O: 0.8%
H: 10.28%
C: -0.4%
FMC | News P | $53.78 -2.96% 0.45% 1.7M
|
Process Industries
|
| O: 0.74%
H: 0.0%
C: 0.0%
JRVR | News | $9.36 -0.21% -0.21% 830K
|
Finance
|
| O: -0.21%
H: 0.0%
C: 0.0%
company health beauty skin
Gainers vs Losers
| 55% | 45% |
Top 10 Gainers
ZVSA | $2.03 3179.48% 96.95% 330K
|
CHSN | $4.89 68.63% 45.9% 5.7M
|
ANY M | $1.72 60.75% 37.79% 26M
|
Technology Services
VCXA | News 0 d | $15.88 60.57% 37.72% 82K
|
CNET | News | $1.12 60.0% 37.5% 3.8M
|
Commercial Services
MFH | $1.62 37.29% 27.16% 6.5M
|
Technology Services
AIHS | $0.4389 37.16% 27.09% 230K
|
Finance
KALA | $8.83 36.06% 26.5% 2.7M
|
Health Technology
JNVR | $1.53 29.66% 21.33% 2.8M
|
WHLR 4 | $0.3532 26.14% 20.72% 14M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.